1. Home
  2. BIO vs PATH Comparison

BIO vs PATH Comparison

Compare BIO & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$298.85

Market Cap

8.0B

Sector

Industrials

ML Signal

N/A

Logo UiPath Inc.

PATH

UiPath Inc.

N/A

Current Price

$12.39

Market Cap

7.9B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BIO
PATH
Founded
1952
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Computer Software: Prepackaged Software
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.9B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BIO
PATH
Price
$298.85
$12.39
Analyst Decision
Strong Buy
Hold
Analyst Count
4
15
Target Price
$358.50
$15.50
AVG Volume (30 Days)
232.0K
27.8M
Earning Date
02-12-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.42
Revenue
$2,557,500,000.00
$1,553,111,000.00
Revenue This Year
$1.50
$13.59
Revenue Next Year
$2.23
$9.54
P/E Ratio
N/A
$28.73
Revenue Growth
N/A
10.05
52 Week Low
$211.43
$9.38
52 Week High
$351.02
$19.84

Technical Indicators

Market Signals
Indicator
BIO
PATH
Relative Strength Index (RSI) 46.43 34.07
Support Level $298.09 $11.62
Resistance Level $307.41 $12.53
Average True Range (ATR) 8.89 0.67
MACD -0.23 -0.22
Stochastic Oscillator 49.88 19.33

Price Performance

Historical Comparison
BIO
PATH

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

Share on Social Networks: